The blockbuster weight-loss drugs Wegovy and Ozempic are arguably as omnipresent in the American zeitgeist as Taylor Swift or the iPhone. The drugs and others in its class are associated with the sparkle of Hollywood, on the lips of Oprah and considered transformative by doctors. But the giant market for drugs like Wegovy, including not […]
Weight loss is a famous side effect of Ozempic, the Type 2 diabetes drug, but patients often find they must avoid certain foods on the medication. It’s a similar story with Wegovy, the form of Ozempic approved for weight loss. Still, the drugs are becoming more popular, changing eating habits for many Americans, and as […]
Amid the growing popularity of drugs used for weight loss like Ozempic, Wegovy, Mounjaro and Zepbound, one question has remained for users, what happens if they were to stay on the drug for years? Now, a new study released earlier this month by Novo Nordisk, the maker of both Ozempic and Wegovy, is shedding light […]
Novo Nordisk (NVO) stock was trading down Thursday despite strong first quarter results, beating Wall Street consensus, led by the blockbuster GLP-1s Ozempic for diabetes and Wegovy for weight loss. Novo posted total sales up 25%, totaling $9.5 billion in revenue from all of its drugs and beating estimates of $9.2 billion. Wegovy brought in […]
(Adds Ozempic price drop in paragraph 1) LONDON, May 2 (Reuters) – Novo Nordisk has seen the price of its hugely popular weight-loss drug Wegovy and diabetes drug Ozempic fall in the United States as volumes and competition have increased, a senior executive said on Thursday. Wegovy prices in the United States were “slightly down” […]
Novo Nordisk (NVO) stock eased a fraction early Thursday after the weight-loss drugs leader reported adjusted income of 81 cents per share on $9.36 billion in first-quarter sales. X On average, analysts surveyed by FactSet expected Novo to earn 75 cents a share on $9.13 billion in sales. Notably, weight-loss drug Wegovy soared 106%, to […]
Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a new dilemma: What happens if they stop taking them? Many worry, rightly, that they’ll regain weight and revert to old habits. In clinical trials, patients who paused the drugs put back on most of the […]
By Rishika Sadam HYDERABAD, India (Reuters) – Indian drugmakers aiming to grab a slice of the burgeoning weight-loss treatment sales pie, both at home and abroad, have begun developing their own versions of Novo Nordisk’s wildly in demand Wegovy. With some analysts predicting a weight-loss market reaching $100 billion a year or more by the […]
In 2015, the Danish drugmaker Novo Nordisk announced plans to double its facility footprint in Johnston County with a $1.85 billion investment, then the largest manufacturing commitment in state history. Signs suggest another major expansion could be coming. In an interview last week with Yahoo Finance, Novo Nordisk chief financial officer Karsten Munk Knudsen said […]
(Bloomberg) — Novo Nordisk A/S agreed to buy three manufacturing plants for $11 billion to help it meet surging demand for the obesity drug Wegovy and diabetes shot Ozempic. Most Read from Bloomberg Novo is paying its main shareholder, Novo Holdings A/S, in cash for the fill-finish sites. Novo Holdings on Monday agreed to buy […]
(Bloomberg) — Novo Nordisk A/S became the second-ever European company to pass $500 billion in market value, bolstered by an upbeat outlook for its blockbuster obesity drug. Most Read from Bloomberg Novo crossed the milestone on Wednesday, reaching a level only attained by Dior owner LVMH, as its shares extended recent gains. The Danish pharma […]
Weight-loss drugs were this year’s most searched health trend in Yahoo Search, and for good reason: 2023 was flooded with headlines about how the injections and pills can help people lose a significant amount of weight, along with the risks and complications that can go along with using them. Much of the popularity of weight-loss […]